Licensing Agreements

Partnerships Financial Transactions Drug Development Strategic Partnerships Lupin Pharmaceuticals Co-Marketing Drug Commercialization Market Competition Global Collaborations Market Authorization Market Expansion Biotechnology Collaboration International Deals Collaboration Agreements Drug Partnerships Clinical Development Eurofarma International Partnerships Generic Production Collaborations

3 ARTICLES

3w ago

Spero Licenses Innovent’s Anti‑CD40L Antibody Outside Greater China in Up to $1.1 Billion Deal

The agreement gives Innovent immediate cash plus milestone and royalty upside while positioning Spero to build an immunology program and advance mid‑stage trials next year.

5 ARTICLES

3w ago

AstraZeneca Licenses Global Rights to Zegfrovy From Dizal

4 ARTICLES

2mo ago

Lilly Secures Global Rights to Hanmi’s Sonefpeglutide

3 ARTICLES

5mo ago

Pfizer to Commercialize Sciwind’s GLP-1 Ecnoglutide in China Under Exclusive License

9 ARTICLES

6mo ago

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

8 ARTICLES

8mo ago

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

9 ARTICLES

9mo ago

Novo Nordisk Licenses Omeros’ MASP-3 Drug in Deal Worth Up to $2.1 Billion

8 ARTICLES

last yr.

GSK Closes $12 Billion Licensing Pact for Hengrui’s COPD Therapy and 11 Preclinical Assets